Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, Washington, United States. The firm focuses on decoding and analyzing the human immune system to address various diseases.
Subscribe to see Adaptive Biotechnologies Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, United States. It is publicly listed (ADPT) with a market capitalisation of $4.2B. Xcout tracks 22 named people at Adaptive Biotechnologies Corp., including Chad Robins (Chief Executive Officer, Co-founder, Chairman of the Board). Xcout recorded 38 job postings from Adaptive Biotechnologies Corp. in the last 90 days, naming tools such as Salesforce, ServiceNow, Workday.
16 more named people on record for Adaptive Biotechnologies Corp., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $195.1M | — |
Some filings are not shown as funding rounds.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 38 job postings from Adaptive Biotechnologies Corp. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Adaptive Biotechnologies Corp.'s hiring signals →
A few of Adaptive Biotechnologies Corp.'s closest competitors — see the full list of competitors and alternatives →
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Cofactor Genomics develops RNA-Seq technology and predictive diagnostics to help match cancer patients with appropriate immunotherapy treatments. The company offers tools such as the OncoPrism assay and collaborates with healthcare systems and clinical researchers to evaluate multidimensional biomarkers for various solid tumor cancers.
Precede Biosciences is a biotechnology company developing blood-based liquid-biopsy technologies for molecular profiling of cancer. Its tests are intended to support oncology research, precision treatment decisions, and pharmaceutical drug-development programs.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.